Nasdaq Breaks Key Support as Apple Tumbles; Market Finds Silver Lining in Weakness

Few stocks are flashing buy signals in this weakening market.
The silver lining to Thursday's broad selloff is that investors can more easily stay disciplined.
Mark

So we had a bad day in the market. How bad are we talking?

Mimi

The Nasdaq fell 3.5%, the S&P 500 dropped 3.2%, and the Dow sank 2.3%. All three major indexes broke below their 50-day moving averages for the first time in over a month. That's the kind of move that signals a real shift in momentum.

Luke

But let's be precise about what "broke below" means. These are technical levels that traders watch, but they're not magic. The market had been rallying since October 13. Is this the end of that rally, or just a pullback? The article says "it's too soon to say."

Mark

What spooked investors?

Mimi

Multiple things hit at once. Retail sales came in weak, regional Fed surveys showed contraction, China's economic data disappointed, and the Fed is still signaling it wants to keep rates high. Jobless claims actually fell, which sounds good, but the Fed doesn't want that right now—they want a weaker labor market to cool inflation.

Luke

Right, so the economic signals are genuinely mixed. Weak consumer spending and manufacturing, but a still-resilient job market. That's a confusing picture, which is probably why the market sold off—uncertainty.

Mark

Which stocks got hit the hardest?

Mimi

The megacaps that had led the rally. Apple fell 4.7%, its worst day since late September. Amazon dropped 3.4% and is approaching bear-market lows. Microsoft retreated 3.2%. Nvidia fell 4.1% and broke below its 200-day line. The chip sector as a whole was crushed.

Luke

And Elon Musk sold $3.6 billion worth of Tesla stock over three days, which probably didn't help investor sentiment. Though the article notes that disclosure likely means his selling is done.

Mark

Is there anything good here?

Mimi

Adobe beat on earnings and popped 5% after hours. Exact Sciences surged 20% on good news about a competitor's clinical trial. A few stocks held support on earnings.

Luke

But those are exceptions. The article is clear: "Most leading stocks came under pressure." And here's the thing—if you bought on dips over the past few weeks, you're probably underwater now because the indexes are undercutting their recent lows.

Mark

So what should investors do?

Mimi

The silver lining is that few stocks are flashing buy signals right now. It's actually easier to stay disciplined and sit on the sidelines. Reduce exposure, update your watchlists, and wait for clearer signals.

Luke

But stay engaged. A couple of good days could revive the rally. The article says the market direction is still uncertain—we don't know if this is the end of the two-month rally or just a deeper pullback. That uncertainty is exactly why you don't want to make big moves right now.

  • All three major U.S. indexes shattered their 50-day moving averages simultaneously — a technical alarm bell that hadn't rung in over a month and signals deteriorating market momentum.
  • Apple, Amazon, Nvidia, and Microsoft — the very stocks that had carried the market higher — led the collapse, with some approaching or breaching bear-market lows set months earlier.
  • Weak retail sales, grim regional Fed surveys, soft Chinese economic data, and a labor market too strong for the Fed's comfort all arrived at once, leaving bulls with nowhere to hide.
  • Tesla hit a fresh two-year low intraday while Elon Musk disclosed billions in fresh share sales, compounding investor frustration with a stock already down 12% on the week.
  • A handful of exceptions — Adobe's after-hours earnings pop, Exact Sciences' 20% surge — offered isolated relief but did little to alter the broad picture of deterioration.
  • The clearest guidance for investors may be the absence of buy signals itself: with few tempting entries, discipline becomes easier, and the wisest move may simply be to wait.

On a Thursday in mid-December 2022, the American stock market delivered one of its sharpest rebukes in months, as the Nasdaq, S&P 500, and Dow all broke beneath key technical thresholds that investors had watched as signs of resilience. The selling was not born of a single fear but of many converging ones — a hawkish Federal Reserve, weakening data from both the American consumer and Chinese industry, and the creeping suspicion that the autumn rally was never a new beginning, only a pause in a longer decline. In moments like these, markets do not merely move prices; they force a reckoning with what was hoped for and what is actually true.

Thursday's session was a rout by nearly any measure. The Nasdaq fell 3.5%, the S&P 500 dropped 3.2%, and the Dow suffered its worst day in three months, sinking 2.3%. All three major indexes broke below their 50-day moving averages for the first time in over a month — a shift in momentum that left investors scrambling to reassess what the autumn rally had actually meant.

The triggers were numerous and arrived from multiple directions. November retail sales declined an unexpected 0.6%. Regional Fed surveys from Philadelphia and New York both pointed to December contraction. China reported weaker industrial production and retail figures, raising doubts about global growth even as it rapidly dismantled Covid restrictions — a move some economists fear could unleash a wave of infections that further disrupts activity. And the Federal Reserve's hawkish posture on interest rates cast a shadow over everything. Even a meaningful drop in jobless claims landed badly: a tight labor market is precisely what the Fed does not want while trying to cool inflation.

The damage fell hardest on the stocks that had led the market's recovery. Apple tumbled 4.7% to its worst single day since late September, now trading within reach of its June bear-market low. Amazon sank toward its own bear-market floor. Nvidia dropped below its 200-day moving average just three sessions after reclaiming it, compounded by HSBC initiating coverage with a reduce rating and a price target well below current levels. Tesla briefly hit a two-year intraday low before closing slightly positive — though it remained down 12% for the week, with Elon Musk having disclosed $3.6 billion in fresh share sales days prior.

Bright spots existed but were narrow. Adobe beat earnings expectations and guided higher on profits after the close, popping 5% in after-hours trading. Exact Sciences surged more than 20% after a rival's colorectal cancer test earned Medicare reimbursement eligibility — a win that paradoxically crushed Guardant Health, maker of the competing product, by nearly 40%.

Broader market health measures told a consistent story of retreat. Growth-focused ETFs were hammered, the ARK Innovation ETF fell nearly 5%, and energy prices softened while the 10-year Treasury yield dipped — a move that read less as inflation relief and more as recession anxiety.

The deeper question now is whether the two-month rally from October's lows was a genuine new uptrend or simply a bear-market bounce running out of breath. Major indexes have returned to levels last seen in mid-November, and the Nasdaq trades near where it stood on the very day a follow-through signal had suggested recovery was underway. Yet the silver lining is real: with few conventional buy signals flashing, disciplined investors find it easier to stay on the sidelines rather than chase moves that may reverse sharply. The market's direction remains uncertain, but the discipline it demands is becoming unmistakable.

Thursday's stock market session was a rout. The Nasdaq composite fell 3.5%, the S&P 500 dropped 3.2%, and the Dow Jones Industrial Average sank 2.3%—its worst day in three months. All three major indexes broke below their 50-day moving averages for the first time in just over a month, signaling a shift in momentum that has left investors scrambling to reassess their positions.

The selling had multiple triggers. Before the market opened, November retail sales came in unexpectedly weak, declining 0.6%. Regional Federal Reserve surveys from Philadelphia and New York both pointed to economic contraction in December. Across the Pacific, China reported weaker-than-expected industrial production and retail sales figures, raising concerns about global growth even as the country rapidly eases its Covid restrictions—a move that economists worry could unleash a massive wave of infections that might further dampen economic activity. The Federal Reserve's hawkish stance on interest rates, made clear in recent communications, hung over the entire session like a weight. Jobless claims did decline significantly, but that news landed poorly: the Fed does not want to see a tight labor market when it is trying to cool inflation through rate hikes.

The damage was concentrated in the stocks that had led the market higher. Apple tumbled 4.7% to 136.60, marking its worst single day since late September. The stock is now trading near its October-November lows, with the June bear-market low of 129.04 within striking distance. Amazon sank 3.4% to 88.45, approaching its November 9 bear-market low of 85.87. Microsoft retreated 3.2% to 249.01, finding support at its 21-day moving average but having tested its 200-day line in the two sessions prior. Nvidia fell 4.1% to 169.52, dropping below its 200-day line after having reclaimed that level just three trading days earlier. The chip sector as a whole was battered, with the VanEck Vectors Semiconductor ETF tumbling 3.8%. HSBC initiated coverage of Nvidia with a reduce rating and a price target of 136, well below where the stock was trading. Tesla dipped to a fresh two-year low of 153.28 in the morning before rebounding to close up 0.5% at 157.67, though the stock remains down 12% for the week. Late Wednesday, CEO Elon Musk had disclosed selling 22 million Tesla shares between December 12 and 14 for $3.6 billion, adding to investor frustration.

There were a handful of bright spots. Adobe reported better-than-expected fourth-quarter earnings late Thursday and guided slightly higher on fiscal first-quarter earnings, though it guided lower on revenue. The stock popped 5% in after-hours trading despite closing down 3.3% during the regular session. Exact Sciences surged more than 20% after a rival's clinical trial results for a colorectal cancer blood test proved strong enough to qualify for Medicare reimbursement—a win that paradoxically hurt Guardant Health, which makes the competing test and saw its stock crash nearly 40%. A few individual stocks found support on earnings, including Lennar and Nordson, but these were exceptions in a broad selloff.

Broad measures of market health deteriorated. The Russell 2000 small-cap index skidded 2.5%. Growth-focused ETFs were hammered: the iShares Expanded Tech-Software Sector ETF fell 3.5%, while the ARK Innovation ETF sold off 4.9%, trading just above its five-month low. The ARK Genomics ETF retreated 3.5% to a six-month closing low. Energy prices weakened, with crude oil retreating 1.5% to $76.11 a barrel and gasoline futures slumping 3.5%, though natural gas prices leapt 8.4%. The 10-year Treasury yield fell 5 basis points to 3.45%, a move that likely reflected recession fears rather than any easing of inflation pressures.

The question now is whether the market's two-month rally from the October 13 low to the December 13 high was merely a bear-market bounce that is now exhausting itself. All major indexes are at their lowest levels since November 10, when they gapped up on better-than-expected October consumer price index data. The Nasdaq is trading near where it was on October 21, the day of the follow-through signal that had suggested a new uptrend was beginning. Investors who bought on relative weakness over recent weeks—pulling back to the 21-day moving average, for instance—are now seeing those positions underwater as the indexes undercut their recent lows.

There is, however, a silver lining in the wreckage. Few stocks are flashing conventional buy signals in this environment. The market weakness has made it easier for disciplined investors to stay on the sidelines rather than chase stocks that might reverse sharply lower. The danger in choppy markets is that they tempt investors into positions that immediately reverse, locking in losses. For now, the path of least resistance is to reduce exposure and wait for clearer signals. A couple of strong days could revive the rally and push stocks back into buy areas, so investors are advised to keep their watchlists updated and monitor which stocks are holding key support levels like the 21-day or 50-day lines. The market direction remains uncertain, but the discipline required in this environment is becoming clearer by the day.

The market is no longer tempting investors into taking new positions.
— Market analysis in the article
Few stocks are flashing buy signals while the market is clearly weakening. It's easier to stay out in that environment.
— Market strategy guidance in the article
Contattaci Domande frequenti